Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 57,203 | 57,929 | 42,599 | 77,493 | 63,274 |
| Cost of Goods | 2,124 | 2,575 | 704 | 2,975 | 2,753 |
| Gross Profit | 55,079 | 55,354 | 41,895 | 74,518 | 60,521 |
| Operating Expenses | 51,585 | 52,857 | 55,681 | 65,865 | 65,499 |
| Operating Income | 3,618 | 3,072 | -13,082 | 9,628 | -4,225 |
| Interest Expense | 14,842 | 16,554 | 16,613 | 17,190 | 17,010 |
| Other Income | -1,240 | -609 | 224 | 62,677 | 67 |
| Pre-tax Income | -12,464 | -14,091 | -29,471 | 55,115 | -21,168 |
| Income Tax | 1,141 | 210 | -5,333 | 6,845 | -120 |
| Net Income Continuous | -13,605 | -14,301 | -24,138 | 48,270 | -21,048 |
| Net Income | $-13,605 | $-14,301 | $-24,138 | $48,270 | $-21,048 |
| EPS Basic Total Ops | -0.84 | -0.88 | -1.52 | 3.04 | -1.32 |
| EPS Basic Continuous Ops | -0.84 | -0.89 | -1.52 | 3.02 | -1.32 |
| EPS Diluted Total Ops | -0.84 | -0.88 | -0.92 | 2.60 | -1.32 |
| EPS Diluted Continuous Ops | -0.84 | -0.89 | -0.37 | 2.34 | -1.32 |
| EBITDA(a) | $35,187 | $35,226 | $18,194 | $42,031 | $28,063 |